An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines
New filling line approval supports delivery of integrated, end-to-end solutions across the entire biologics and bioconjugates value chain
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
Our specialty chemical businesses have continued to perform strongly, growing double digit YoY
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
The state-of-the-art facility is equipped with best-in-class equipment and control systems
Wacker Biotech US, a wholly owned subsidiary of Wacker Chemie AG, specializes in the microbial production of pDNA
The campaign marks an important milestone in its journey within the pharmaceutical manufacturing industry
Subscribe To Our Newsletter & Stay Updated
